Abstract
Objectives:
Evidences from randomized clinical trials and meta-analysis have claimed an association between the use of soluble dietary fiber from psyllium and a cholesterol-lowering effect. However, there is still uncertainty as to the dose–response relationship and its long-term lipid-lowering efficacy. This meta-analysis was primarily conducted to address the dose–response relationship between psyllium and serum cholesterol level and time-dependent effect of psyllium in mild-to-moderate hypercholesterolemic subjects.
Methods:
Twenty-one studies, which enrolled a total of 1030 and 687 subjects receiving psyllium or placebo, respectively, were included in the meta-analysis. The studies were randomized placebo-controlled trials, double blinded or open label, on subjects with mild-to-moderate hypercholesterolemia. The dose of psyllium was between 3.0 and 20.4 g per day and intervention period was more than 2 weeks. Any type of diet background was permitted. Diet lead-in period was between 0 and 8 weeks.
Results:
Compared with placebo, consumption of psyllium lowered serum total cholesterol by 0.375 mmol/l (95% CI: 0.257–0.494 mmol/l), and LDL cholesterol by 0.278 mmol/l (95% CI: 0.213–0.312 mmol/l). With random-effect meta-regression, a significant dose–response relationship were found between doses (3–20.4 g/day) and total cholesterol or LDL cholesterol changes. Regression model of total cholesterol was −0.0222+0.2061 × log (dose+1), and that of LDL cholesterol was 0.0485+0.1390 × log (dose+1). There was a time effect of psyllium on total cholesterol (equation: 6.3640–0.0316 × treatment period) and on LDL cholesterol (equation: 4.3134–0.0162 × treatment period), suggesting that psyllium reduced serum total cholesterol more quickly than LDL cholesterol.
Conclusions:
Psyllium could produce dose- and time-dependent serum cholesterol-lowering effect in mild and moderate hypercholesterolemic patients and would be useful as an adjunct to dietary therapy for the treatment of hypercholesterolemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adult Treatment Panel III (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285, 2486–2497.
Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA et al. (2000a). Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 71, 472–479.
Anderson JW, Davidson MH, Blonde L, Brown WV, Howard WJ, Ginsberg H et al. (2000b). Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 71, 1433–1438.
Anderson JW, Floore TL, Geil PB, O'Neal DS, Balm TK (1991). Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjuncts to dietary therapy in mild to moderate hypercholesterolemia. Arch Intern Med 151, 1597–1602.
Anderson JW, Riddell-Mason S, Gustafson NJ, Smith SF, Mackey M (1992). Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr 56, 93–98.
Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW (1988). Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemia. Arch Intern Med 148, 292–296.
Anne W (2002). Meta-Analysis of Controlled Clinical Trial. The Atrium, Southern Gate, John Wiley & Sons Ltd: Chichester, West Sussex, England.
Bell LP, Hectorne KJ, Reynolds H, Balm TK, Hunninghake DB (1989). Cholesterol-lowering effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 261, 3419–3423.
Bell LP, Hectorn KJ, Reynolds H, Hunninghake DB (1990). Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr 52, 1020–1026.
Berkey CS, Hoaglin DC, Mosteller F, Colditz GA (1995). A random-effects regression models for meta-analysis. Stat Med 14, 395–411.
Betteridge DJ (1994). Cholesterol lowering and CHD prevention: time to get on with it. Br J Clin Pract 48, 115–117.
Brown L, Rosner B, Willett WW, Sacks FM (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30–42.
Brunner EJ, Rees K, Ward K, Burke M, Thorogood M (2007). Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 17, CD002128.
Davidson MH, Maki KC, Kong JC, Dugan LD, Torri SA, Hall HA et al. (1998). Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr 67, 367–376.
Egger M, Davey Smith G, Schneider M, Minder CE (1997). Bias in meta-analysis detected by a simple, graphical test. Br Med J 315, 629–634.
Everson GT, Daggy BP, McKinley C, Story JA (1992). Effects of psyllium hydrophilic mucilloid on LDL cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res 33, 1183–1192.
Flannery J, Raulerson A (2000). Hypercholesterolemia: a look at low-cost treatment and treatment adherence. J Am Acad Nurse Pract 12, 462–466.
Garvin JE, Forman DT, Eiseman WR, Phillips CR (1965). Lowering of serum cholesterol by oral hydrophilic colloid. Proc Soc Exp Biol Med 120, 744–746.
Houwelingen HC, Arends LR, Stijnen T (2002). Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21, 589–624.
Jenkins DJ, Wolever TM, Vidgen E, Kendall CW, Ransom TP, Mehling CC et al. (1997). Effect of psyllium in hypercholesterolemia at two monounsaturated fatty acid intakes. Am J Clin Nutr 65, 1524–1533.
Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paolrtti R (2003). Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78, 965–978.
Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC (1990). Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 150, 1822–1827.
Maciejko JJ, Brazg R, Shah A, Patil S, Rubenfire M (1994). Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia. Arch Fam Med 3, 955–960.
MacMahon M, Carless J (1998). Ispaghula husk in the treatment of hypercholesterolemia: a double-blind controlled study. J Cardiovasc Risk 5, 167–172.
Moreyra AE, Wilson AC, Koraym A (2005). Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Intern Med 165, 1161–1166.
Neal GW, Balm TK (1990). Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. South Med J 83, 1131–1137.
Olson BH, Anderson SM, Becker MP, Anderson JW, Hunninghake DB, Jenkins DJ et al. (1997). Psyllium-enrich cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr 127, 1973–1980.
Petchetti L, Frishman WH, Petrillo R, Raju K (2007). Nutriceuticals in cardiovascular disease: psyllium. Cardiol Rev 15, 116–122.
Roberts DC, Truswell AS, Bencke A, Dewar HM, Farmakalidis E (1994). The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre. Med J Aust 161, 660–664.
Romero AL, Romero JE, Galaviz S, Fernandez ML (1998). Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico. J Am Coll Nutr 7, 601–608.
Shrestha S, Volek JS, Udani J, Wood RJ, Greene CM, Aggarwal D et al. (2006). A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr 136, 2492–2497.
Singh B (2007). Psyllium as therapeutic and drug delivery agent. Int J Pharm 334, 1–14.
Spence JD, Huff MW, Heidenheim P, Viswanatha A, Munoz C, Lindsay R et al. (1995). Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Intern Med 123, 493–499.
Sprecher DL, Harris BV, Goldberg AC, Anderson EC, Bayuk LM, Russell BS et al. (1993). Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med 119, 545–554.
Stoy DB, LaRosa JC, Brewer BK, Mackey M, Meusing RA (1993). Cholesterol-lowering effects of ready-to-eat cereal containing psyllium. J Am Diet Assoc 93, 910–912.
Summerbell CD, Manley P, Barnes D, Leeds A (1994). The effects of psyllium on blood lipids in hypercholesterolaemic subjects. J Hum Nutr Diet 7, 147–151.
Wolever TM, Jenkins DJ, Mueller S, Boctor DL, Ransom TP, Patten R et al. (1994). Method of administration influences the serum cholesterol-lowering effect of psyllium. Am J Clin Nutr 59, 1055–1059.
Wolever TM, Jenkins DJ, Mueller S, Patten R, Relle LK, Boctor D et al. (1994). Psyllium reduces blood lipids in men and women with hyperlipidemia. Am J Med Sci 307, 269–273.
Acknowledgements
This work was partially supported by Cooperative Program of Rhone-Alps Region and Shanghai. We thank Professor Jean-Pierre Boissel and Dr Michael Cucherat (Institute of Clinical Pharmacology, Lyon University I, France) for expert advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wei, Zh., Wang, H., Chen, Xy. et al. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. Eur J Clin Nutr 63, 821–827 (2009). https://doi.org/10.1038/ejcn.2008.49
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2008.49